Dr. Yogesh received his doctoral degree from Chungnam University, S. Korea, where he worked with Prof. Eunhee Kim’s in biological sciences. After completing his PhD, Dr. Dayma join Koch institute at MIT for his post-doctoral research in oncology. He authored several scientific research articles in the field of oncology drug discovery, immunology and computational biology.

After his scientific career Dr. Dayma ended up in banking sector and specialized in healthcare/life-science investment. He has been covering the biopharma sector for over five years. His work primarily focused on private fundraising, capital market and merger & acquisition and advisory services exclusively to the Biopharma/Life Sciences sector. Dr. Dayma has completed more than 25 transactions including cross-border transactions over the course of his career for public and private life sciences companies.